CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 566054-566233 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T50532","span":{"begin":0,"end":179},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"On each Nanofluidics PCR 48X48 Fluidigm chips, 15 samples (14 tumors and A4573 positive control) were simultaneously tested for 38 fusions in triplicates on BioMark HD instrument."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T262","span":{"begin":0,"end":179},"obj":"Sentence"}],"text":"On each Nanofluidics PCR 48X48 Fluidigm chips, 15 samples (14 tumors and A4573 positive control) were simultaneously tested for 38 fusions in triplicates on BioMark HD instrument."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2721","span":{"begin":62,"end":68},"obj":"Disease"},{"id":"T2722","span":{"begin":165,"end":167},"obj":"Disease"},{"id":"T27435","span":{"begin":62,"end":68},"obj":"Disease"},{"id":"T72101","span":{"begin":165,"end":167},"obj":"Disease"}],"attributes":[{"id":"A2721","pred":"mondo_id","subj":"T2721","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A2722","pred":"mondo_id","subj":"T2722","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"},{"id":"A84316","pred":"mondo_id","subj":"T27435","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A69617","pred":"mondo_id","subj":"T72101","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"}],"text":"On each Nanofluidics PCR 48X48 Fluidigm chips, 15 samples (14 tumors and A4573 positive control) were simultaneously tested for 38 fusions in triplicates on BioMark HD instrument."}